Literature DB >> 26998203

Prevalence Of Diabetic Retinopathy In A Primary Care Setting Using Digital Retinal Imaging Technology.

Keah Say Hien1, Chng Kooi Seng2.   

Abstract

The objective of this study was to determine the prevalence of diabetic retinopathy in a primary care setting using digital retinal imaging technology and to quantify the degree of diabetic retinopathy using internationally accepted severity scales. Two hundred patients with type 2 diabetes were evaluated clinically followed by fundus photography. The prevalence of retinopathy and maculopathy was 47.4% and 59.2% respectively (both retinopathy and maculopathy 34.7%). The high prevalence of retinal abnormality in this study is a cause for concern as most patients had diabetes for only 5 years or less.

Entities:  

Keywords:  diabetic retinopathy; diabetic retinopathy severity scales; digital retinal imaging

Year:  2006        PMID: 26998203      PMCID: PMC4797044     

Source DB:  PubMed          Journal:  Malays Fam Physician        ISSN: 1985-2274


  9 in total

1.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

Authors:  I M Stratton; A I Adler; H A Neil; D R Matthews; S E Manley; C A Cull; D Hadden; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

2.  Diabetes control and complications in private primary healthcare in Malaysia.

Authors:  M Mafauzy
Journal:  Med J Malaysia       Date:  2005-06

3.  An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study.

Authors:  A Y T Wu; N C T Kong; F A de Leon; C Y Pan; T Y Tai; V T F Yeung; S J Yoo; A Rouillon; M R Weir
Journal:  Diabetologia       Date:  2004-12-23       Impact factor: 10.122

4.  Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

5.  Addition of primary care-based retinal imaging technology to an existing eye care professional referral program increased the rate of surveillance and treatment of diabetic retinopathy.

Authors:  Charlton Wilson; Mark Horton; Jerry Cavallerano; Lloyd M Aiello
Journal:  Diabetes Care       Date:  2005-02       Impact factor: 19.112

Review 6.  Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.

Authors:  C P Wilkinson; Frederick L Ferris; Ronald E Klein; Paul P Lee; Carl David Agardh; Matthew Davis; Diana Dills; Anselm Kampik; R Pararajasegaram; Juan T Verdaguer
Journal:  Ophthalmology       Date:  2003-09       Impact factor: 12.079

7.  The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years.

Authors:  R Klein; B E Klein; S E Moss; M D Davis; D L DeMets
Journal:  Arch Ophthalmol       Date:  1984-04

8.  Comparison of the effectiveness of detecting diabetic eye disease: diabetic retinal photography versus ophthalmic consultation.

Authors:  D S Y Chia; E Y Yap
Journal:  Singapore Med J       Date:  2004-06       Impact factor: 1.858

9.  Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform.

Authors:  J C Javitt; L P Aiello; Y Chiang; F L Ferris; J K Canner; S Greenfield
Journal:  Diabetes Care       Date:  1994-08       Impact factor: 19.112

  9 in total
  2 in total

1.  Risk factors for diabetic retinopathy in diabetics screened using fundus photography at a primary health care setting in East malaysia.

Authors:  Ps Mallika; Py Lee; Wl Cheah; Js Wong; Sar Syed Alwi; H Nor Hayati; Ak Tan
Journal:  Malays Fam Physician       Date:  2011-08-31

2.  National Eye Institute Visual Function Scale in Type 2 Diabetes Patients.

Authors:  Sezen Akkaya; Sinay Düzova; Özlem Şahin; Haluk Kazokoğlu; Tayfun Bavbek
Journal:  J Ophthalmol       Date:  2016-02-21       Impact factor: 1.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.